David-Erick Lafontant

Author

Also Known As

David-Erick LaFontant, David-Erick Lafontant, Hyunkeun Ryan Cho, Lafontant, David-Erick, for the Parkinson’s Progression Markers Initiative

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Iowa University of Pennsylvania Massachusetts General Hospital Northwestern University University of Miami

About

David-Erick Lafontant is an author at University of Iowa specializing in medicine, neurodegenerative diseases, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	650
2	Health Sciences	1	1	21
3	Diabetes	1	1	21
4	Endocrinology	1	1	21
5	Metabolism	1	1	21

David-Erick Lafontant

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, The Lancet Neurology Neurodegenerative DiseasesDisease ProgressionParkinson DiseaseNeurologyMedicine	2023	618
National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities Camillo Ricordi, Julia Goldstein, Appakalai N. Balamurugan, Diabetes	2016	191
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease Tanya Simuni, Brian Fiske, Kalpana Merchant, JAMA Neurology	2020	133
Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia Eric D. Foster, Nancy D. Bridges, Irene D. Feurer, Diabetes Care	2018	116
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older Michael C. Brumm, Kerri A. Pierz, David-Erick Lafontant, Neurology	2023	61
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study Michael R. Rickels, Thomas L. Eggerman, Levent Bayman, Diabetes Care	2022	46
Age dependence of glucose tolerance in adult KK-Ay mice, a model of non–insulin dependent diabetes mellitus Goutam Chakraborty, Sherin Thumpayil, David-Erick Lafontant, Lab Animal Metabolic SyndromeDevelopmental BiologyAdult Kk-ay MiceMedicinePhysiology	2009	21
Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease Alberto J. Espay, David-Erick Lafontant, Kathleen L. Poston, Parkinsonism & Related Disorders Neuroimaging BiomarkersNeurodegenerative DiseasesNeurochemical BiomarkersSmaller Brain VolumeNeurology	2021	11

Page 1